Stamenkovic, Ivan

Systematic identification of genomic markers of drug sensitivity in cancer cells

Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature

Cancer Genomics and DiagnosticsLung Cancer Treatments and Mutations

Cited by 2,456

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis

Yu, Q., & Stamenkovic, I. (2000) · Genes & Development

Protease and Inhibitor MechanismsTGF-β signaling in diseases

Cited by 1,754

IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer

Degrauwe, N., Suvà, M.-L., Janiszewska, M., Riggi, N., & Stamenkovic, I. (2016) · Genes & Development

RNA Research and SplicingDevelopmental Biology and Gene Regulation

Cited by 324

Mesenchymal stromal cells in cancer: A review of their immunomodulatory functions and dual effects on tumor progression

Galland, S., & Stamenkovic, I. (2020) · The Journal of Pathology

Mesenchymal stem cell researchCancer Cells and Metastasis

Cited by 165

The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing

Degrauwe, N., Schlumpf, T. B., Janiszewska, M., Martin, P., Cauderay, A., Provero, P., Riggi, N., Suvà, M.-L., Paro, R., & Stamenkovic, I. (2016) · Cell Reports

MicroRNA in disease regulationCancer-related molecular mechanisms research

Cited by 136